Compare OPAD & SINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OPAD | SINT |
|---|---|---|
| Founded | 2015 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.1M | 11.7M |
| IPO Year | 2020 | 2007 |
| Metric | OPAD | SINT |
|---|---|---|
| Price | $1.35 | $1.15 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $12.25 | $9.25 |
| AVG Volume (30 Days) | ★ 32.1K | 26.6K |
| Earning Date | 11-02-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 33.92 | ★ 59.45 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $567,812,000.00 | $1,018,000.00 |
| Revenue This Year | N/A | $230.23 |
| Revenue Next Year | $63.55 | $112.70 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.54 | $1.18 |
| 52 Week High | $6.09 | $4.46 |
| Indicator | OPAD | SINT |
|---|---|---|
| Relative Strength Index (RSI) | 17.59 | 22.02 |
| Support Level | $0.63 | N/A |
| Resistance Level | $5.51 | $1.86 |
| Average True Range (ATR) | 0.21 | 0.17 |
| MACD | -0.04 | -0.04 |
| Stochastic Oscillator | 3.36 | 8.95 |
Offerpad Solutions Inc provides a way to buy and sell a home. It uses technology-enabled solutions to remake the home selling and buying experience by offering customers the convenience, control, and certainty to solve their housing needs. It combines fundamental real estate expertise with the data-driven digital Solutions Center platform to efficiently sell and buy their homes online with streamlined access to other services, including mortgage, listing, renovation, and buyer representation services.
SINTX Technologies Inc is a biomaterials company that develops, manufactures, and commercializes patented and proprietary silicon nitride ceramic biomaterials, composites, devices, and related ceramics technologies for other medical and specialized industrial applications. SINTX has 20 years' experience innovating silicon nitride technologies and operates under a quality management system certified to ISO 13485:2016 and AS9100D, with a product portfolio that includes insulators for Tier 1 aerospace suppliers, the FDA-cleared SiNAPTIC Foot & Ankle Osteotomy Wedge System for reconstructive surgery, OEM manufacturing of FDA-cleared spinal implants, and its SiNERGY technology platform being developed for biocomposite and 3D printing applications.